Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 28, 2022
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
Fri, November 25, 2022
[ Fri, Nov 25th 2022
] - WOPRAI
[ Fri, Nov 25th 2022
] - WOPRAI
[ Fri, Nov 25th 2022
] - WOPRAI
[ Fri, Nov 25th 2022
] - WOPRAI
[ Fri, Nov 25th 2022
] - WOPRAI
[ Fri, Nov 25th 2022
] - WOPRAI
[ Fri, Nov 25th 2022
] - WOPRAI
Thu, November 24, 2022
[ Thu, Nov 24th 2022
] - WOPRAI
Wed, November 23, 2022
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
[ Wed, Nov 23rd 2022
] - WOPRAI
Phil Winslow Initiated (SOPH) at Hold and Held Target at $2 on, Nov 23rd, 2022
Phil Winslow of Credit Suisse, Initiated "SOPHiA GENETICS SA" (SOPH) at Hold and Held Target at $2 on, Nov 23rd, 2022.
Phil has made no other calls on SOPH in the last 4 months.
There is 1 other peer that has a rating on SOPH. Out of the 1 peers that are also analyzing SOPH, 0 agree with Phil's Rating of Hold.
This is the rating of the analyst that currently disagrees with Phil
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $12 on, Wednesday, November 9th, 2022
